ACD/Labs is holding its first ever Virtual Symposium on Thursday, June 14th from 10:30 AM–2:00 PM. EST! Join from your desk when convenient for you—whether it’s for an hour or for the entire session—to learn about our NMR, Luminata and Percepta platforms, and how they can be used to improve processes in the lab for the remainder of 2018. Experts at Procter & Gamble, Amgen, and Cayman Chemical, as well as members from the ACD/Labs team, will join each session to share tips on best practices and their unique applications of our software.
Ever wonder what goes in to exhibiting at a major analytical science tradeshow? I’m glad you asked! Earlier this year I had the opportunity to travel to Pittcon 2018 (Feb 26 – Mar 1) for my first scientific conference as a member of industry, and an exhibitor rather than as an academic. I’ll take you behind the scenes of ACD/Labs’ conference machine to give you an idea of what it’s really like to exhibit at a conference.
PANIC 2018 explored the many ways applied NMR is being used in practical day-to-day applications and reaffirmed that with innovation comes a drive for knowledge management.
As Pittcon 2018 approaches, we are eagerly preparing for one of our biggest meetings of the year! In 2018 the annual Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy will be held at the Orange County Convention Center in Orlando from Monday, February 26th to Thursday, March 1st.
Andrew Anderson reports on the 2017 AAPS Annual Conference by taking a closer look at his recent byline in Laboratory Equipment. He also introduces Joe DiMartino, ACD/Labs' newly appointed solution manager for Luminata, and previews Joe's recent Q&A with Outsourcing-Pharma.com, which discusses how QbD and impurity control management directly impact process development within pharmaceutical R&D organizations.
Join us next week in beautiful Baveno, Italy, for SMASH 2017. This year’s organizing committee took the light-hearted step of naming each session/workshop after the name of a popular song. Staying with this theme, we are organizing our Software Symposium titled “Stairway to Heaven” on Sunday, Sept. 17th, where we intend to present to you all of the very exciting developments in the world of ACD/Labs.
The fascinating world of metabolite identification is something I’ve been learning a lot about recently. The process of drug discovery to drug development to meeting regulations, and the complicated (often manual) workflow. My informant is colleague, Richard Lee. An easy-going and friendly guy with a vast resource of information ranging from metabolite research to cheesy chick flicks (don’t tell him I shared the latter). Read on to learn more about his research and what we'll be discussing at ASMS 2017 this week!
If you happen to be at Bio-IT World this year, be sure to stop by booth #423 to meet the ACD/Labs team and learn more about our solutions; including our new impurity profile information management solution Luminata. We’ll be busy with a number of activities in addition to networking with our fellow peers. Read on for an overview of what our team has planned for the show and where you can find us.
PITTCON 2017 was a particularly big event for the ACD/Labs team this year because we were focused on the launch of Luminata, our new informatics solution for comprehensive impurity and characterization management. The five days we spent in Chicago were the culmination of months of hard work across the entire organization, and I’m pleased to say that the launch went off without a hitch. I had the opportunity to meet with the folks at LabTube to talk about ACD/Labs and our vision for Luminata. Watch the video in our post.
Back in 1996, I recall someone saying that prediction software such as ACD/Labs NMR Predictors would eliminate the need to run lab experiments, which would be replaced with “paper chemistry”. Organic chemistry researchers were even more cynical because they believed that nomenclature software - like ACD/Name - would enable students to avoid learning nomenclature rules. Overall, the faculty were concerned that ACD/NMR Predictors and ACD/Name put their jobs at risk. Fast-forward 21 years later, and I find myself a part of the ACD/Labs team that makes all these wonderful things possible.